Your session is about to expire
← Back to Search
Breastfeeding Promotion for Postpartum Smoking Relapse
N/A
Waitlist Available
Led By Xiaozhong Wen
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months postpartum
Awards & highlights
Study Summary
This trial is testing whether a breastfeeding intervention can help prevent postpartum smoking relapse.
Who is the study for?
This trial is for women over 18 who quit smoking during or before their current pregnancy and are pregnant or up to one month postpartum. They must be open to learning about infant care and breastfeeding, and able to communicate in English. Women using illicit drugs, against breastfeeding, with certain medical conditions like HIV or active tuberculosis, or heavy drinkers cannot join.Check my eligibility
What is being tested?
The study is testing if teaching new moms how to breastfeed effectively can prevent them from starting to smoke again after having a baby. Half of the participants will get special breastfeeding support while the other half will receive general baby care advice as a comparison.See study design
What are the potential side effects?
Since this trial involves education and counseling rather than medication, there aren't typical side effects like you'd see with drugs. However, participants may experience stress or discomfort related to lifestyle changes encouraged by the interventions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 9 months postpartum
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months postpartum
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rates of smoking relapse
Secondary outcome measures
Breastfeeding duration
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Breastfeeding intervention groupExperimental Treatment1 Intervention
A multicomponent behavioral intervention to promote breastfeeding
Group II: Attention placebo control groupPlacebo Group1 Intervention
General infant care counseling and support
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Breastfeeding promotion
2019
N/A
~1280
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
246 Previous Clinical Trials
49,442 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,479 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,964 Previous Clinical Trials
2,674,670 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be able to understand, speak, and read in English.You are currently using illegal drugs.You strongly oppose breastfeeding.You cannot breastfeed due to medical conditions such as HIV infection, active tuberculosis, or having had a breast removal surgery.You drink more than two alcoholic beverages per day.
Research Study Groups:
This trial has the following groups:- Group 1: Breastfeeding intervention group
- Group 2: Attention placebo control group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this clinical experiment currently recruiting participants?
"Affirmative. Clinicaltrials.gov hosts data that supports the fact that this scientific investigation, which was first published on July 31st 2018, is currenly accepting participants. Sixty people need to be taken from one medical centre for full inclusion in the study."
Answered by AI
How many individuals have been chosen to participate in this trial?
"Affirmative. Clinicaltrials.gov provides confirmation that this clinical trial, which began recruiting participants on July 31st 2018 and was last modified on October 24th 2022, is actively seeking applicants. Sixty test subjects are needed from a single research centre."
Answered by AI
Share this study with friends
Copy Link
Messenger